FilingsAtlas Logo - Company Search & Market Tools
FilingsAtlas

OneMedNet Corp (ONMD) Financial Statements

Industry: Commercial Physical & Biological Research (Services)

In fiscal 2025, OneMedNet reported revenue of $1.4M, up 111.4% from $643,000 the year before. Net income was -$2.8M (a -206.1% net margin), or -$0.60 per diluted share. Gross margin was -37.0% and operating margin was -711.3%. Operating activities generated -$7.5M of cash, leaving -$7.5M of free cash flow. At fiscal year end, OneMedNet held $2.2M in total assets against $5.1M in total liabilities, including $585,000 of cash and equivalents.

Open the full interactive OneMedNet financials → Quarterly statements, key ratios, valuation history and price charts.

OneMedNet Key Stats

Share Price$4.02
Market Cap$23.3M
Revenue YoY Growth+111.3%
52-Week Range$3.93 – $30.00
Shares Outstanding5.8 million (basic, 2026 Q2)

OneMedNet Income Statement

OneMedNet Corp annual income statement
FY 2022FY 2023FY 2024FY 2025
Revenue$0$1.0M$643,000$1.4M
Cost of Goods Sold$0———
Gross Profit$0-$127,900-$281,000-$503,000
Operating Income-$5.3M-$8.4M-$9.6M-$9.7M
Pre-Tax Income$551,508-$23.2M-$10.1M-$2.8M
Income Tax$214,850—$2,000$1,000
Net Income$336,658-$23.2M-$10.1M-$2.8M
Diluted EPS$0.30-$9.80-$3.60-$0.60

OneMedNet Quarterly Results

OneMedNet Corp last 4 quarters
2025 Q32025 Q42026 Q12026 Q2
Revenue$177,000$890,000$96,000$292,000
Net Income-$741,000-$3.1M-$2.5M-$2.2M
Diluted EPS-$0.10-$0.07-$0.40-$0.40

OneMedNet Balance Sheet

OneMedNet Corp annual balance sheet (fiscal year end)
FY 2022FY 2023FY 2024FY 2025
Cash & Equivalents$30,870$47,008$172,000$585,000
Current Assets$30,870$364,186$3.6M$2.1M
Total Assets$29.1M$463,057$3.7M$2.2M
Current Liabilities$2.0M$12.8M$19.2M$4.8M
Total Long-Term Debt—$38,921$2.3M$220,000
Total Liabilities$9.1M$13.3M$19.7M$5.1M
Shareholders' Equity-$8.8M-$12.9M-$15.9M-$3.0M

OneMedNet Cash Flow Statement

OneMedNet Corp annual cash flow statement
FY 2022FY 2023FY 2024FY 2025
Cash From Operations-$940,463$8.2M-$7.0M-$7.5M
Cash From Investing-$2.2M—-$2.0M$2.3M
Cash From Financing$2.8M-$8.4M$9.1M$5.6M
Free Cash Flow—$8.2M-$7.0M-$7.5M

Figures from OneMedNet's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full OneMedNet financials page for every line item.

OneMedNet Company Profile

TickerONMD
ExchangeNasdaq
IndustryCommercial Physical & Biological Research (Services)
HeadquartersSurrey, United Kingdom
Incorporated inDelaware
Fiscal Year EndDecember 31
SEC Filer CategoryEmerging growth company
SEC CIK0001849380

Frequently Asked Questions

What was OneMedNet's revenue in fiscal 2025?

OneMedNet (ONMD) reported revenue of $1.4M for fiscal 2025.

What is OneMedNet's annual revenue history?

OneMedNet's annual revenue by fiscal year: 2022: $0; 2023: $1.0M; 2024: $643,000; 2025: $1.4M.

What was OneMedNet's net income in fiscal 2025?

OneMedNet reported net income of -$2.8M for fiscal 2025.

What was OneMedNet's earnings per share (EPS) in fiscal 2025?

OneMedNet's diluted EPS was -$0.60 for fiscal 2025 (adjusted for any later stock splits).

How much free cash flow did OneMedNet generate in fiscal 2025?

OneMedNet generated -$7.5M of free cash flow in fiscal 2025.

What was OneMedNet's revenue last quarter?

In its most recent reported quarter (2026 Q2), OneMedNet reported revenue of $292,000.

How much debt does OneMedNet have?

OneMedNet reported $220,000 of long-term debt, including the current portion, at the end of fiscal 2025.

How many shares of OneMedNet are outstanding?

OneMedNet reported a weighted average of 5.8 million basic shares outstanding in 2026 Q2.

What is OneMedNet's market cap?

Based on its latest closing price, OneMedNet (ONMD) has a market capitalization of about $23.3M.

When does OneMedNet's fiscal year end?

OneMedNet's fiscal year end, as registered with the SEC, is December 31.

Where is OneMedNet headquartered?

OneMedNet lists its business address in Surrey, United Kingdom in its SEC filings.